Integration of high‐risk human papillomavirus into cellular cancer‐related genes in head and neck cancer cell lines

Human papillomavirus (HPV)‐positive oropharyngeal cancer is generally associated with excellent response to therapy, but some HPV‐positive tumors progress despite aggressive therapy. The purpose of this study was to evaluate viral oncogene expression and viral integration sites in HPV16‐ and HPV18‐positive squamous cell carcinoma lines.

[1]  Petar Stojanov,et al.  Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas , 2014, Clinical Cancer Research.

[2]  A. Giuliano,et al.  HEAD AND NECK SQUAMOUS CELL CANCER AND THE HUMAN PAPILLOMAVIRUS: SUMMARY OF A NATIONAL CANCER INSTITUTE STATE OF THE SCIENCE MEETING, , 2009 .

[3]  G. Stenman.  Fusion Oncogenes in Salivary Gland Tumors: Molecular and Clinical Consequences , 2013, Head and Neck Pathology.

[4]  T. Carey,et al.  Genotyping of 73 UM‐SCC head and neck squamous cell carcinoma cell lines , 2009, Head & neck.

[5]  D. Pim,et al.  Interaction of viral oncoproteins with cellular target molecules: infection with high‐risk vs low‐risk human papillomaviruses , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[6]  Y. Tanga,et al.  Sensitive detection of human papillomavirus in cervical, head (cid:1) neck, and schistosomiasis-associated bladder malignancies , 2005 .

[7]  A. Eisbruch,et al.  High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods. , 2013, JAMA otolaryngology-- head & neck surgery.

[8]  W. Quint,et al.  Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck , 2003, International journal of cancer.

[9]  R. Schlegel,et al.  Molecular mechanisms of transformation by the human papillomaviruses. , 1989, Princess Takamatsu symposia.

[10]  A. Yang,et al.  A C-Terminal Inhibitory Domain Controls the Activity of p63 by an Intramolecular Mechanism , 2002, Molecular and Cellular Biology.

[11]  M. Gillison,et al.  Clinical implications of human papillomavirus in head and neck cancers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  L. Bonello,et al.  Detection of human papillomavirus type 16 integration in pre-neoplastic cervical lesions and confirmation by DIPS-PCR and sequencing. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  A. Giuliano,et al.  Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C. , 2009, Head & neck.

[14]  Jeremy MG Taylor,et al.  Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. , 2007, International journal of radiation oncology, biology, physics.

[15]  Lars Jansen,et al.  Non-Random Integration of the HPV Genome in Cervical Cancer , 2012, PloS one.

[16]  Benjamin J. Raphael,et al.  Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.

[17]  Shinichiro,et al.  Carcinoma , 1906, The Hospital.

[18]  A. Carvalho,et al.  Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. , 2006, Cancer research.

[19]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[20]  T. Tokino,et al.  deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. , 2003, Oncogene.

[21]  F. Feng,et al.  HPV‐positive/p16‐positive/EBV‐negative nasopharyngeal carcinoma in white North Americans , 2009, Head & neck.

[22]  M. Grce,et al.  Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. , 2009, Gynecologic oncology.

[23]  R. Swaminathan,et al.  Prognostic significance of HPV physical status and integration sites in cervical cancer. , 2009, Asian Pacific journal of cancer prevention : APJCP.

[24]  E. De Braekeleer,et al.  ETV6 fusion genes in hematological malignancies: a review. , 2012, Leukemia research.

[25]  C. Martin,et al.  The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. , 2007, Oral oncology.

[26]  A. Kibel,et al.  Mutational analysis of ETV6 in prostate carcinoma , 2002, The Prostate.

[27]  T. Iftner,et al.  High-Risk Human Papillomaviruses Repress Constitutive Kappa Interferon Transcription via E6 To Prevent Pathogen Recognition Receptor and Antiviral-Gene Expression , 2011, Journal of Virology.

[28]  Jason I. Herschkowitz,et al.  ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. , 2007, Cancer cell.

[29]  L. Turek,et al.  Human Papillomavirus Type 16 (HPV-16) Genomes Integrated in Head and Neck Cancers and in HPV-16-Immortalized Human Keratinocyte Clones Express Chimeric Virus-Cell mRNAs Similar to Those Found in Cervical Cancers , 2010, Journal of Virology.

[30]  Chandra Sekhar Pedamallu,et al.  Characterization of HPV and host genome interactions in primary head and neck cancers , 2014, Proceedings of the National Academy of Sciences.

[31]  C. Gerharz,et al.  Establishment and characterization of four cell lines derived from human head and neck squamous cell carcinomas for an autologous tumor-fibroblast in vitro model. , 1999, Anticancer research.

[32]  F. Feng,et al.  Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence , 2010, Clinical Cancer Research.

[33]  E. Leo,et al.  Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion , 2009, Journal of medical virology.

[34]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[35]  E. Speel,et al.  Viral load, gene expression and mapping of viral integration sites in HPV16‐associated HNSCC cell lines , 2015, International journal of cancer.

[36]  P. Lambert,et al.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Thomas Ried,et al.  Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. , 2008, Oral oncology.

[38]  M. Gillison,et al.  Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. , 2004, Seminars in oncology.

[39]  M. von Knebel Doeberitz,et al.  Detection of integrated papillomavirus sequences by ligation‐mediated PCR (DIPS‐PCR) and molecular characterization in cervical cancer cells , 2001, International journal of cancer.

[40]  R. Ferris,et al.  Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. , 2005, European journal of cancer.

[41]  R. Schlegel,et al.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes , 1989, Journal of virology.

[42]  S. Franceschi,et al.  Eurogin Roadmap: Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix , 2014, International journal of cancer.

[43]  T. Carey,et al.  Evidence that loss of chromosome 18q is associated with tumor progression. , 1997, Cancer research.

[44]  K. Ogawa,et al.  Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma , 2013, Head & neck.

[45]  Zhi-Ming Zheng,et al.  Papillomavirus genome structure, expression, and post-transcriptional regulation. , 2006, Frontiers in bioscience : a journal and virtual library.

[46]  S. Gollin,et al.  Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line , 2004, International journal of cancer.

[47]  A. Chaturvedi,et al.  Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  Jordi Giralt,et al.  Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. , 2010, The Lancet. Oncology.

[49]  Elizabeth E. Hoskins,et al.  Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus , 2011, Head & neck.

[50]  J. McCoy,et al.  The E7 Oncoprotein Is Translated from Spliced E6*I Transcripts in High-Risk Human Papillomavirus Type 16- or Type 18-Positive Cervical Cancer Cell Lines via Translation Reinitiation , 2006, Journal of Virology.

[51]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[52]  Shih-hung Huang,et al.  Integration of human papillomavirus correlates with high levels of viral oncogene transcripts in cervical carcinogenesis. , 2011, Virus research.

[53]  Gary L. Gallia,et al.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal , 2013, Proceedings of the National Academy of Sciences.

[54]  C. Meijer,et al.  Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. , 1995, Cancer research.

[55]  T. Ried,et al.  Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability , 2014, Genome research.

[56]  T. Carey,et al.  UM‐SCC‐104: A New human papillomavirus‐16–positive cancer stem cell–containing head and neck squamous cell carcinoma cell line , 2012, Head & neck.

[57]  F. Feng,et al.  Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: Clinical and functional results , 2011 .

[58]  Mihaela Campan,et al.  Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer , 2008, Molecular Cancer.

[59]  W. Westra,et al.  Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. , 2008, Journal of the National Cancer Institute.

[60]  Guy N Brock,et al.  Interrogating differences in expression of targeted gene sets to predict breast cancer outcome , 2013, BMC Cancer.

[61]  S. Vinokurova,et al.  Systematic Review of Genomic Integration Sites of Human Papillomavirus Genomes in Epithelial Dysplasia and Invasive Cancer of the Female Lower Genital Tract , 2004, Cancer Research.

[62]  E. Speel,et al.  Marked differences in survival rate between smokers and nonsmokers with HPV 16‐associated tonsillar carcinomas , 2008, International journal of cancer.

[63]  T. Tokino,et al.  ΔNp63α functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes , 2003, Oncogene.

[64]  M. von Knebel Doeberitz,et al.  Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. , 1999, Cancer research.

[65]  V. Balz,et al.  p53, p63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposure. , 2005, Advances in oto-rhino-laryngology.

[66]  L. Licitra,et al.  A multidisciplinary approach to squamous cell carcinomas of the head and neck: what is new? , 2006, Current opinion in oncology.

[67]  D. Merico,et al.  Transcriptional Network of p63 in Human Keratinocytes , 2009, PloS one.

[68]  M. Hoeckel,et al.  A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques , 2003, Oncogene.

[69]  C. Van Waes,et al.  TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer. , 2011, Cancer research.

[70]  N. Coleman,et al.  Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis? , 2007, The Journal of pathology.

[71]  E. Speel,et al.  Integration of HPV6 and Downregulation of AKR1C3 Expression Mark Malignant Transformation in a Patient with Juvenile-Onset Laryngeal Papillomatosis , 2013, PloS one.

[72]  J. Manola,et al.  Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6–7, 2011, Arlington, Virginia , 2012, Head & neck.

[73]  A. Papavassiliou,et al.  Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer , 2004, Journal of Cancer Research and Clinical Oncology.